Recombinant Human CD33 protein (rFc Tag) (HPLC verified)
Species
Human
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg2138
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human CD33 protein Asp18-His259 (Accession# AAH28152.1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 945 |
Accession | AAH28152.1 |
PredictedSize | 53.0 kDa |
SDS-PAGE | 60-85 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
CD33, also known as sialic acid-binding Ig-like lectin 3 (Siglec-3) or gp67, is a 67-kDa type I transmembrane glycoprotein of sialic acid-binding immunoglobulin-like lactic (Siglec) family, a discrete subset of the immunoglobulin (Ig) superfamily molecules. It contains an amino-terminal V-set Ig-like domain and a C2-set Ig-like domain in its extracellular region, a transmembrane region, and two conserved tyrosine-based inhibitory signaling motif in its cytoplasmic region. Alternative splicing of CD33 RNA leads to a shorter isoform. CD33 is expressed on myeloid progenitors, granulocytes, monocytes, macrophages, dendritic cells, mast cells, subsets of activated T- and NK cells. It may mediate cell-to-cell adhesion and act as a receptor that inhibits the proliferation of normal and leukemic myeloid cells.
References:
1. E J Favaloro, et al. (1988) Br J Haematol. 69(2):163-71. 2. S D Freeman, et al. (1995) Blood. 85(8):2005-12. 3. C Vitale, et al. (1999) Proc Natl Acad Sci U S A. 96(26):15091-6. 4. Trinidad Hernández-Caselles, et al. (2006) J Leukoc Biol. 79(1):46-58. 5. George S Laszlo, et al. (2014) Blood Rev. 28(4):143-53.